BANK VONTOBEL/CALL/MERCK & CO./150/0.1/20.12.24

BANK VONTOBEL/CALL/MERCK & CO./150/0.1/20.12.24 Stock

DE000VD3VZN9

Market Closed - Bid/Ask 01:50:43 2024-06-04 pm EDT			Pre-market 02:03:01 am
0.158 ^EUR	+3.95%		0.172	+8.86%

Current month	+30.58%
1 month	-6.51%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart MERCK & CO., INC.

Chart BANK VONTOBEL/CALL/MERCK & CO./150/0.1/20.12.24

Latest news about MERCK & CO., INC.

Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	Jun. 04	AQ
Transcript : Merck & Co., Inc. Presents at 2024 American Society of Clinical Oncology Annual Meeting, Jun-03-2024 06:00 PM	Jun. 03
Merck: promising results in melanoma treatment	Jun. 03	CF
Merck, Moderna Drug Combo Shows Improved Survival in Skin Cancer Trial	Jun. 03	DJ

More news

Quotes 5-day view

Date	Price	Change
24-06-04	0.158	+3.95%
24-06-03	0.152	+25.62%
24-05-31	0.121	-16.55%
24-05-30	0.145	+18.85%
24-05-29	0.122	0.00%

Real-time Boerse Frankfurt Warrants

Last update June 04, 2024 at 01:50 pm EDT

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	MERCK & CO., INC.
Issuer	Vontobel
WKN	VD3VZN
ISIN	DE000VD3VZN9
Date issued	2024-04-10
Strike	150 $
Maturity	2024-12-20 (199 Days)
Parity	10 : 1
Emission price	0.21 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.29 €
Lowest since issue	0.118 €
Spread	0.01 €
Spread %	5.88%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).

Sector

More about the company